Clinical Trial Update: Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis [NA]

View source ↗

Summary

A Bayer-sponsored clinical trial evaluating a new topical formulation for atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Topical formulation for atopic dermatitis (unspecified)

Snippet

Sponsor: Bayer | Conditions: Dermatitis, Atopic | NA | Status: WITHDRAWN